Company: SCLXW
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001193125-25-172703
Chunk: 150

Company: Scilex Holding Co
Filing Date: 2025-08-04
Form: S-1
Chunk 150
---
 Stock being registered for resale under this prospectus, depending on the market price of our Common Stock prior to each VWAP Purchase made pursuant to the Tumim Purchase Agreement, the actual gross proceeds from the sale of all such shares may be substantially less than the $100,000,000 available to us under the Tumim Purchase Agreement, which could materially adversely affect our liquidity.

If it becomes necessary for us to issue and sell to the Selling Stockholder under the Tumim Purchase Agreement more than the 1,390,443 shares being registered for resale under this prospectus in order to receive aggregate gross proceeds equal to $100,000,000 under the Tumim Purchase Agreement, we must file with the SEC one or more additional registration statements to register under the Securities Act the resale by the Selling Stockholder of any such additional shares of our Common Stock we wish to sell from time to time under the Tumim Purchase Agreement, which the SEC must declare effective. Additionally, we would need to obtain stockholder approval to issue shares of Common Stock in excess of the Exchange Cap under the Tumim Purchase Agreement in accordance with applicable Nasdaq Listing Rules, unless the average price of all applicable sales of our Common Stock to the Selling Stockholder under the Tumim Purchase Agreement equals or exceeds $8.09 (which is the “Minimum Price” (as such term is defined in Rule 5635 of the Nasdaq Listing Rules)), such that such issuances and sales of our Common Stock to Tumim under the Tumim Purchase Agreement would be exempt from the Exchange Cap limitation under applicable Nasdaq Listing Rules. Any issuance and sale by us under the Tumim Purchase Agreement of shares of Common Stock in addition to the 1,390,443 shares of Common Stock being registered for resale by the Selling Stockholder under the registration statement of which this prospectus forms a part could cause additional dilution to our stockholders.

We are not required or permitted to issue any shares of Common Stock under the Tumim Purchase Agreement if such issuance would breach our obligations under the rules or regulations of Nasdaq. In addition, the Selling Stockholder will not be required to purchase any shares of our Common Stock if such sale or additional sale would result in the Selling Stockholder’s beneficial ownership exceeding 4.99% of the then outstanding voting power or number of Common Stock. Our inability to access a part or all of the amount available under the Tumim Purchase Agreement, in the absence of any other financing sources, could have